Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification
about
Cholangiocarcinoma: Current Knowledge and New DevelopmentsStereotactic Body Radiotherapy (SBRT) for Intrahepatic and Hilar Cholangiocarcinoma.The Roles of MicroRNA-122 Overexpression in Inhibiting Proliferation and Invasion and Stimulating Apoptosis of Human Cholangiocarcinoma CellsForty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise.Schisandrin B inhibits cell proliferation and induces apoptosis in human cholangiocarcinoma cells.Current biologics for treatment of biliary tract cancers.Increased incidence but improved median overall survival for biliary tract cancers diagnosed in Ontario from 1994 through 2012: A population-based study.Sex-specific and race/ethnicity-specific disparities in cholangiocarcinoma incidence and prevalence in the USA: An updated analysis of the 2000-2011 Surveillance, Epidemiology and End Results registry.Biliary tract malignancies: a population-based study on incidence, prognosis and management of patients.Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.The prognostic potential and carcinogenesis of long non-coding RNA TUG1 in human cholangiocarcinoma.Long non-coding RNA UCA1 indicates an unfavorable prognosis and promotes tumorigenesis via regulating AKT/GSK-3β signaling pathway in cholangiocarcinoma.Fyn knockdown inhibits migration and invasion in cholangiocarcinoma through the activated AMPK/mTOR signaling pathway.Cholangiocarcinoma--current classification and challenges towards personalised medicine.Methylation-Mediated Silencing of GATA5 Gene Suppresses Cholangiocarcinoma Cell Proliferation and Metastasis.Cohort contributions to trends in the incidence and mortality of intrahepatic cholangiocarcinoma
P2860
Q28076098-E3DB0CD3-7CEF-45FB-B532-0230A9AD41A0Q36190116-CFB749EC-AD1E-426E-947E-019F6000BE3FQ36388133-95DB3CF7-090B-4BE6-9C96-E61C0307D670Q36884411-CF36FBD4-F865-480A-92FE-28F209966A5CQ38753244-281C23DF-9FE9-48E9-B158-1496C41BAF40Q39453572-F6499258-FB16-44DA-A69E-A5E69F55FBA5Q39763484-6BC85E4F-874E-41B9-9670-E3DA188D6494Q40385793-2358FE52-BE90-4411-BD77-CC9C1FA10559Q40610628-58A7E931-65BB-486C-93EA-2684332B4B5AQ41991379-C4FA2ECC-B78C-437C-97C9-A7780A75044FQ42371588-CC110F60-8ED9-426D-89C0-47963101F519Q47156270-141604B2-8E6D-4477-AF00-ADC3FAC5B735Q50053633-38CF00BF-AA02-4719-832E-C645B192E28FQ51548085-605A8C32-7DC0-4363-8EB3-EC2EA23DF79EQ54999003-32A8506C-8809-4772-81D4-48FFECB07560Q58804371-9AEF5CDA-3EB5-4B80-AD6E-6834B4ABD841
P2860
Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Secular trends in the incidenc ...... he impact of misclassification
@ast
Secular trends in the incidenc ...... he impact of misclassification
@en
type
label
Secular trends in the incidenc ...... he impact of misclassification
@ast
Secular trends in the incidenc ...... he impact of misclassification
@en
prefLabel
Secular trends in the incidenc ...... he impact of misclassification
@ast
Secular trends in the incidenc ...... he impact of misclassification
@en
P2093
P2860
P1476
Secular trends in the incidenc ...... he impact of misclassification
@en
P2093
Gia L Tyson
Hashem B El-Serag
Jawad A Ilyas
Jessica A Davila
Linda K Green
Zhigang Duan
P2860
P2888
P304
P356
10.1007/S10620-014-3276-2
P577
2014-09-10T00:00:00Z